(Q36881409)

16 August 2017

1 reference

title

Osteoporosis, schizophrenia and antipsychotics: the need for a comprehensive multifactorial evaluation (English)

1 reference

16 August 2017

0 references

Uriel Halbreich

1

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

21

1 reference

16 August 2017

issue

8

1 reference

16 August 2017

page(s)

641-657

1 reference

https://scigraph.springernature.com/pub.10.2165/00023210-200721080-00003

16 August 2017

exact match

0 references

cites work

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Testosterone and calcitonin plasma levels in hypogonadal osteoporotic young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Decreased bone mineral density in medicated psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Cortisol secretion in endogenous depression. I. Basal plasma levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Relation of Plasma Prolactin to Clinical Response in Schizophrenic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

Urinary excretion levels of hydroxylysine glycosides in osteoporotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00023210-200721080-00003

The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations

21 January 2018

1 reference

12 December 2020

Osteopenia Associated with Increased Prolactin and Aging in Psychiatric Patients Treated with Prolactin-Elevating Antipsychotics

1 reference

12 December 2020

Effects of elevated serum prolactin on bone mineral density and bone metabolism in female patients with schizophrenia: a prospective study

1 reference

12 December 2020

Vitamin D receptor gene polymorphisms do not predict bone turnover and bone mass in healthy premenopausal women

1 reference

12 December 2020

Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction

1 reference

12 December 2020

Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment

1 reference

12 December 2020

Recombinant murine interferon-gamma inhibits the fusion of mouse alveolar macrophages in vitro but stimulates the formation of osteoclastlike cells on implanted syngeneic bone particles in mice in vivo

1 reference

12 December 2020

Bone density in amenorrheic women with and without hyperprolactinemia

1 reference

12 December 2020

Schizophrenia and osteoporosis

1 reference

12 December 2020

Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus

1 reference

12 December 2020

Systematic review of randomized trials of the effect of exercise on bone mass in pre- and postmenopausal women

1 reference

12 December 2020

Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation

1 reference

12 December 2020

Reduced calcitonin reserve in young hypogonadic osteoporotic men.

1 reference

12 December 2020

Bone mineral density in diagnosis of osteoporosis: reference population, definition of peak bone mass, and measured site determine prevalence

1 reference

12 December 2020

Side effect profiles of new antipsychotic agents

1 reference

12 December 2020

Osteoporosis in patients with schizophrenia

1 reference

12 December 2020

Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia?

1 reference

12 December 2020

Clinical review 117: Hormonal determinants and disorders of peak bone mass in children

1 reference

12 December 2020

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

1 reference

12 December 2020

Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study

1 reference

12 December 2020

Prediction of bone density from vitamin D receptor alleles

1 reference

12 December 2020

Heritable and life-style determinants of bone mineral density

1 reference

12 December 2020

Bone mineral density in women with depression.

1 reference

12 December 2020

Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom

1 reference

12 December 2020

Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin

1 reference

12 December 2020

Dopaminergic factors in human prolactin regulation: Effects of neuroleptics and dopamine☆

1 reference

12 December 2020

An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder

1 reference

12 December 2020

Elevated prolactin levels in patients with schizophrenia: mechanisms and related adverse effects

1 reference

12 December 2020

Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women

1 reference

12 December 2020

Reduced bone mineral density in patients with schizophrenia receiving prolactin raising anti-psychotic medication

1 reference

12 December 2020

Hyperprolactinemia and schizophrenia: mechanisms and clinical aspects

1 reference

12 December 2020

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Vitamin D receptor alleles and bone's response to physical activity

1 reference

12 December 2020

Clinical considerations in premenopausal osteoporosis

1 reference

12 December 2020

Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency

1 reference

12 December 2020

Clozapine: plasma levels and prolactin response

1 reference

12 December 2020

Polymorphisms of the interleukin-6 gene are associated with bone mineral density

1 reference

12 December 2020

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

1 reference

12 December 2020

Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice

1 reference

12 December 2020

A meta-analysis of the effects of cigarette smoking on bone mineral density

1 reference

12 December 2020

Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group

1 reference

12 December 2020

Osteoporosis associated with neuroleptic treatment. A case report

1 reference

12 December 2020

Low lumbar bone mineral density in patients with major depression

1 reference

12 December 2020

Atypical antipsychotics in the EPS-vulnerable patient

1 reference

12 December 2020

Osteopenia and bone fractures in a man with anorexia nervosa and hypogonadism

1 reference

12 December 2020

Genetic determinants of bone mass in adults. A twin study

1 reference

12 December 2020

Decreased bone density in hyperprolactinemic women

1 reference

12 December 2020

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

12 December 2020

Substance misuse in patients with schizophrenia: epidemiology and management

1 reference

12 December 2020

Sexual dysfunction and antipsychotic treatment

1 reference

12 December 2020

Estrogen receptor gene polymorphism and bone mineral density at the lumbar spine of pre- and postmenopausal women.

1 reference

12 December 2020

Bone densitometry in the management of Colles' fractures: which site to measure?

1 reference

12 December 2020

Osteoporosis and schizophrenia: can we limit known risk factors?

1 reference

12 December 2020

Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption

1 reference

12 December 2020

Metabolic syndrome and schizophrenia

1 reference

12 December 2020

Gender differences in age at onset of schizophrenia. An overview

1 reference

12 December 2020

Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response

1 reference

12 December 2020

Sex differences in age of symptom onset and first hospitalization in schizophrenia

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group

1 reference

12 December 2020

The Association of Bone Mineral Density with Vitamin D Receptor Gene Polymorphisms

1 reference

12 December 2020

Combination treatment of osteoporosis: a clinical review

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism

1 reference

12 December 2020

The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions--the need for interdisciplinary integration

1 reference

12 December 2020

Bone mineral density and prolactin associations in patients with chronic schizophrenia

1 reference

12 December 2020

Gender differences in schizophrenia

1 reference

12 December 2020

Estradiol levels in psychotic disorders

1 reference

12 December 2020

Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature

1 reference

12 December 2020

Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study

1 reference

12 December 2020

IL-2 induces IL-6 production in human monocytes.

1 reference

12 December 2020

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

12 December 2020

Bone densitometry in premenopausal women: synthesis and review

1 reference

12 December 2020

Early postmenopausal bone loss is associated with PvuII estrogen receptor gene polymorphism in Finnish women: effect of hormone replacement therapy

1 reference

12 December 2020

The second-generation 'atypical' antipsychotics: similar improved efficacy but different neuroendocrine side effects

1 reference

12 December 2020

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

1 reference

12 December 2020

Vitamin D3 and calcium to prevent hip fractures in elderly women

1 reference

12 December 2020

Cognitive effects and antipsychotic treatment.

1 reference

12 December 2020

Osteoporosis--diagnosis, treatment and management

1 reference

12 December 2020

Reduced bone mass in daughters of women with osteoporosis

1 reference

12 December 2020

Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma

1 reference

12 December 2020

Clozapine does not elevate serum prolactin levels in healthy men

1 reference

12 December 2020

Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients

1 reference

12 December 2020

Selective oestrogen receptor modulators--current and future brain and behaviour applications

1 reference

12 December 2020

Genetic control of susceptibility to osteoporosis

1 reference

12 December 2020

Gender differences in schizophrenia

1 reference

12 December 2020

Risk factors for spinal osteoporosis in men

1 reference

12 December 2020

Association of a polymorphism in the TNFR2 gene with low bone mineral density

1 reference

12 December 2020

A longitudinal analysis of premenopausal bone loss in healthy women and women with hyperprolactinemia

1 reference

12 December 2020

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

1 reference

12 December 2020

Neuroleptic-induced hyperprolactinemia

1 reference

12 December 2020

The effect of vitamin D supplementation on the bone mineral density of the femoral neck is associated with vitamin D receptor genotype

1 reference

12 December 2020

Hormonal aspects of schizophrenias: an overview

1 reference

12 December 2020

Strategies for switching from conventional antipsychotic drugs or risperidone to olanzapine.

1 reference

12 December 2020

Molecular basis and clinical application of biological markers of bone turnover

1 reference

12 December 2020

Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders

1 reference

12 December 2020

The epidemiology of early schizophrenia. Influence of age and gender on onset and early course

1 reference

12 December 2020

Bone mineral density, sex hormones, and long-term use of neuroleptic agents in men

1 reference

12 December 2020

Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.

1 reference

12 December 2020

Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia

1 reference

12 December 2020

Hyperprolactinemia and bone mineral density: the potential impact of antipsychotic agents

1 reference

12 December 2020

Effect of clozapine on human serum prolactin levels

1 reference

12 December 2020

Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene

1 reference

12 December 2020

Cytokines and growth factors in the regulation of bone remodeling

1 reference

12 December 2020

Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia.

1 reference

12 December 2020

1 reference

12 December 2020

Vitamin D receptor genotype is not associated with bone mineral density in three ethnic/regional groups

1 reference

12 December 2020

Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence

1 reference

12 December 2020

Elevated levels of soluble interleukin 2 receptors in schizophrenia

1 reference

12 December 2020

1 reference

12 December 2020

Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group

1 reference

12 December 2020

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

12 December 2020

ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group

1 reference

12 December 2020

Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density

1 reference

12 December 2020

PvuII polymorphisms of the estrogen receptor alpha and bone mineral density in healthy southern Chinese women

1 reference

12 December 2020

Drug-induced disorders of vitamin D and mineral metabolism

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Association of bone mineral density with polymorphism of the estrogen receptor gene

1 reference

12 December 2020

Genetic markers, bone mineral density, and serum osteocalcin levels

1 reference

12 December 2020

Genetic influence on bone turnover in postmenopausal twins

1 reference

12 December 2020

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial

1 reference

12 December 2020

Drug-induced bone loss

1 reference

12 December 2020

Segregation analysis and variance components analysis of bone mineral density in healthy families.

1 reference

12 December 2020

Osteopenia, pathological fractures, and increased urinary calcium excretion in schizophrenic patients with polydipsia

1 reference

12 December 2020

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

12 December 2020

Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus

1 reference

12 December 2020

Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients.

1 reference

12 December 2020

Schizophrenia, vitamin D, and brain development

1 reference

12 December 2020

Heritability of bone mass: a longitudinal study in aging male twins

1 reference

12 December 2020

Negative symptoms in schizophrenia: neurobiological models and treatment response

1 reference

12 December 2020

Clinical use of bone densitometry: scientific review

1 reference

12 December 2020

Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial

1 reference

12 December 2020

Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder

1 reference

12 December 2020

Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis

1 reference

12 December 2020

Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia

1 reference

12 December 2020

Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials

1 reference

12 December 2020

Association between estrogen receptor concentration in breast cancer tissue and bone mineral density

1 reference

12 December 2020

10.2165/00023210-200721080-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

16 August 2017

1042262624

0 references

1 reference